Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11-20190----[1] 93 💬
211C-CSar----[2] 93, 94 💬
313-15mg/kg/d Ursodeoxycholic----[1] 93 💬
418-22mg/kg/d Ursodeoxycholic----[1] 93 💬
52mg CS0159----[1] 93 💬
63 mg [14C]-A4250 capsule----[3] 93, 297, 338 💬
73-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-----[1] 93 💬
83-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid----[1] 93 💬
93a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid----[1] 93 💬
103a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid----[1] 93 💬
116 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----[1] 93 💬
126?-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-747[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
136a-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-747[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
146a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid----[1] 93 💬
156a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
166a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
176a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
186a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
196a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid----[1] 93 💬
206a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
216a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
226a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
236a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
24[14C]CS0159----[1] 93 💬
25[GFT505]----[1] 93 💬
26[GKT137831]----[1] 93 💬
27[GSK2330672]----[1] 93 💬
28[INT-747, OCA]----[1] 93 💬
29[LY3009104]----[4] 46, 49, 93, 107 💬
30[MBX-8025]----[1] 93 💬
31[MXB-8025]----[1] 93 💬
32[RhuDex choline salt][1] Choline[1] Choline 💬 --[1] 93 💬
33[volixibat][1] Volixibat[2] Volixibat potassium ,
Volixibat 💬 		--[1] 93 💬
34A11HA02----[1] 93 💬
35A4250----[4] 93, 296, 297, 338 💬
36Abatacept[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[28] 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
37ACIDO OBETICOLICO----[3] 93, 94, 296 💬
38Acido ursodessicolico----[1] 93 💬
39Alkaline Phosphatase[1] Alkaline Phosphatase---[4] 46, 93, 97, 172 💬
40Alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----[1] 93 💬
41APD334----[5] 93, 96, 97, 98, 269 💬
42ASC42 10 mg----[1] 93 💬
43ASC42 15 mg----[1] 93 💬
44ASC42 5 mg----[1] 93 💬
45Atorvastatin[1] Atorvastatin[2] Atorvastatin calcium ,
Atorvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
46Azathioprine[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬 		--[26] 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
47Babaodan Capsule----[1] 93 💬
48Baricitinib[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[24] 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
49BCD-085----[2] 93, 271 💬
50Bezafibrat----[1] 93 💬
51Bezafibrat Genericon retard 400 mg----[1] 93 💬
52Bezafibrate[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[8] 20, 93, 94, 160, 296, 316, 324, 344 💬
53Bezafibrate 100 mg[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
54Bezafibrate 200 MG[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
55Bezafibrate 200 mg in addition to UDCA therapy[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
56Bezafibrate 200 MG Oral Tablet[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
57Bezafibrate 400 MG[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
58Bezafibrate 400 mg in addition to UDCA therapy[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
59Bezafibrate IR[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
60Bezafibrate SR[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
61Bezafibrate, Beza, BZF, Bezalip[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
62Bezafibrate, Beza, BZF, Bezalip mono[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
63Bezafilbrate IR----[1] 93 💬
64Bezalip----[2] 93, 94 💬
65Bezalip mono----[1] 93 💬
66Biological: mesenchymal stem cell----[1] 93 💬
67Blood Draws----[1] 93 💬
68Budenofalk 3mg----[2] 93, 97 💬
69BUDESONIDE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[10] 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
70Calcium[1] Calcium---[39] 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
71Choline[1] Choline[1] Choline 💬 --[4] 93, 171, 193, 299 💬
72Cilofexor[1] Cilofexor---[2] 93, 94 💬
73CNP-104----[1] 93 💬
74CNTO1275----[6] 46, 49, 84, 93, 96, 97 💬
75Colchicine[1] Colchicine[1] Colchicine 💬 [9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[9] 2, 42, 46, 50, 56, 93, 97, 210, 266 💬
76Combination antiviral therapy----[1] 93 💬
77CR845 1.0 mg----[1] 93 💬
78CRC (A3384)----[3] 93, 297, 338 💬
79CS0159----[2] 93, 94 💬
80Cyclophosphamide[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[50] 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
81Cyclosporin A----[12] 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
82Denosumab[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬
83E6011----[4] 46, 93, 96, 97 💬
84EDP-305----[1] 93 💬
85EDP-305 Dose 1----[1] 93 💬
86EDP-305 Dose 2----[1] 93 💬
87ELAFIBRANOR[1] Elafibranor[1] Elafibranor 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 93, 94 💬
88Elafibranor 120 mg[1] Elafibranor[1] Elafibranor 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 93, 94 💬
89Elafibranor 80 mg[1] Elafibranor[1] Elafibranor 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 93, 94 💬
90Elafibranor 80mg[1] Elafibranor[1] Elafibranor 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
91Emtricitabine[1] Emtricitabine[1] Emtricitabine 💬 --[5] 13, 25, 93, 265, 325 💬
92Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)[3] Emtricitabine,
Tenofovir,
Tenofovir disoproxil		[5] Emtricitabine ,
Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--[1] 93 💬
93EP547----[2] 93, 94 💬
94EP547 Tablet 25mg----[2] 93, 94 💬
95EP547 Tablet 75mg----[2] 93, 94 💬
96Experimental: Seladelpar / MBX-8025 200 mg[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
97Experimental: Seladelpar / MBX-8025 50 mg[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
98Ezetimibe[1] Ezetimibe[1] Ezetimibe 💬 [1] NPC1L1 💬 [1] Fat digestion and absorption 💬[5] 49, 79, 93, 149, 260 💬
99EZETROL----[3] 79, 93, 260 💬
100EZT----[1] 93 💬
101FDC tablet (OCA 5 mg + BZF 400 mg SR)----[1] 93 💬
102Fecal microbiota[1] Fecal microbiota---[14] 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
103Fenofibrate[1] Fenofibrate[1] Fenofibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[6] 8, 79, 93, 94, 97, 265 💬
104Fenofibrate 200mg[1] Fenofibrate[1] Fenofibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
105Fenofibrate Combined With Ursodeoxycholic Acid[2] Fenofibrate,
Ursodeoxycholic acid		[2] Fenofibrate ,
Ursodiol 💬 		[2] NR1H4,
PPARA 💬 		[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
106Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)[1] Fenofibrate[1] Fenofibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
107Fenofibrate in Combination With Ursodeoxycholic Acid[2] Fenofibrate,
Ursodeoxycholic acid		[2] Fenofibrate ,
Ursodiol 💬 		[2] NR1H4,
PPARA 💬 		[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
108FFP104----[2] 93, 96 💬
109Fully human monoclonal antibody directed against CXCL10----[1] 93 💬
110Fuzhenghuayu----[1] 93 💬
111Genetic: genetic analysis----[8] 34, 85, 90, 93, 94, 96, 234, 265 💬
112GFT505----[2] 93, 94 💬
113GKT137831----[2] 85, 93 💬
114Gold[1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
115GOLEXANOLONE[1] Golexanolone---[1] 93 💬
116GR3027----[1] 93 💬
117GS-9674----[2] 93, 94 💬
118GS-9674 100 mg----[1] 93 💬
119GS-9674 30 mg----[1] 93 💬
120GSK2330672----[1] 93 💬
121GSK2330672/linerixibat 40 mg[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
122GYPP-06 (GKT137831 free base), C10071301-D----[1] 93 💬
123Hesperidin[1] Hesperidin[1] Hesperidin 💬 --[3] 13, 46, 93 💬
124High protein high fiber diet----[2] 93, 95 💬
125ICG----[3] 93, 94, 235 💬
126INT-747----[1] 93 💬
127INT-747, OCA----[2] 93, 94 💬
128IPN60190----[2] 93, 94 💬
129K-808----[1] 93 💬
130K-808 (Dose A)----[1] 93 💬
131K-808 (Dose B)----[1] 93 💬
132Linerixibat[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
133Linerixibat (GSK2330672) 40 mg[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
134Linerixibat (GSK2330672) 45 mg[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
135Linerixibat (GSK2330672) 45mg[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
136LJN452----[1] 93 💬
137LJN452, 0,01 mg----[1] 93 💬
138LJN452, 0,03 mg----[1] 93 💬
139LJN452, 0,1 mg----[1] 93 💬
140LUM001----[4] 93, 94, 297, 338 💬
141LY3009104----[10] 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
142Mabthera®----[7] 13, 35, 43, 44, 46, 63, 93 💬
143Magnesium[1] Magnesium---[23] 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
144MBX 8025----[1] 93 💬
145MBX-8025----[3] 79, 93, 94 💬
146MBX-8025, DSIC----[1] 93 💬
147MBX-8025, Formulation 2----[1] 93 💬
148Methionine[1] Methionine[1] Methionine 💬 --[9] 34, 75, 84, 93, 94, 229, 298, 300, 337 💬
149Methotrexate[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[41] 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
150Methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[51] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
151Methylprednisolone and azathioprine[2] Azathioprine,
Methylprednisolone		[4] Azathioprine ,
Methylprednisolone ,
Methylprednisolone acetate ,
Azathioprine sodium 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 93, 95 💬
152Methylprednisolone and Mycophenolate mofetil[2] Methylprednisolone,
Mycophenolate mofetil		[4] Methylprednisolone ,
Mycophenolate mofetil ,
Methylprednisolone acetate ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[2] 93, 95 💬
153Minodronic acid[1] Minodronic acid---[4] 6, 46, 93, 95 💬
154MODAFINIL[1] Modafinil[1] Modafinil 💬 --[6] 6, 13, 49, 93, 96, 97 💬
155Moexipril[1] Moexipril[2] Moexipril hydrochloride ,
Moexipril 💬 		[1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 93 💬
156Mycophenolate mofetil[2] Mycophenolate mofetil,
Mycophenolic acid		[4] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		[2] IMPDH1,
IMPDH2 💬 		[2] Drug metabolism - other enzymes, Purine metabolism 💬[38] 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
157Nalmefene[1] Nalmefene[3] Nalmefene hydrochloride ,
Nalmefene ,
Nalmefene hydrochloride hydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 6, 93 💬
158NCA 500mg----[1] 93 💬
159NGM282----[2] 93, 94 💬
160NI-0801----[1] 93 💬
161Non-myeloablative Hematopoietic Stem Cell Transplantation----[1] 93 💬
162Norucholic acid[1] norUrsodeoxycholic acid[1] Norucholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[2] 93, 94 💬
163Norucholic acid (NCA) 500 mg----[1] 93 💬
164Norucholic acid (NCA) 500 mgProduct Code: NCA 500mgPharmaceutical Form: Film-coated tabletINN or Proposed INN: Norucholic acidCAS Number: 9697-24-2Current Sponsor code: NCAOther descriptive name: norucholic acidConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 500-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 93 💬
165Obeticholic Acid[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[3] 93, 265, 296 💬
166Obeticholic Acid (OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
167Obeticholic Acid 10 MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
168Obeticholic Acid 5 MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
169Obeticholic Acid Tablets[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
170Obeticholic Acid Tablets(OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
171OCA----[3] 93, 94, 296 💬
172OCA (INT-747)----[1] 93 💬
173OCA, INT-747----[1] 93 💬
174Ocaliva----[2] 93, 296 💬
175Ocaliva 10mg----[1] 93 💬
176Ocaliva 5mg----[1] 93 💬
177Olumiant----[9] 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
178Other: Questionnaire----[4] 85, 93, 94, 106 💬
179Other: Questionnaire, fasting blood sample----[2] 93, 94 💬
180Other: Questionnaire, semen sample, fasting blood sample----[2] 93, 94 💬
181Part 1: LJN452----[1] 93 💬
182Part 2: LJN452 Dose level 1----[1] 93 💬
183Part 2: LJN452 Dose level 2----[1] 93 💬
184Pemafibrate[1] Pemafibrate[1] Pemafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 67, 93 💬
185Pentoxifylline[1] Pentoxifylline[1] Pentoxifylline 💬 --[13] 6, 26, 46, 56, 84, 93, 96, 97, 113, 222, 223, 296, 298 💬
186Potassium[1] Potassium[1] Potassium 💬 --[17] 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
187Prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[58] 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
188Probiotic----[10] 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
189PVT201----[1] 93 💬
190Pyridoxine[1] Pyridoxine[2] Pyridoxine hydrochloride ,
Pyridoxine 💬 		--[5] 49, 93, 145, 234, 320 💬
191Pyridoxine 10mg[1] Pyridoxine[2] Pyridoxine hydrochloride ,
Pyridoxine 💬 		--[1] 93 💬
192Pyridoxine 10mg BP[1] Pyridoxine[2] Pyridoxine hydrochloride ,
Pyridoxine 💬 		--[1] 93 💬
193Questran----[4] 93, 254, 297, 338 💬
194Raltegravir[1] Raltegravir[2] Raltegravir ,
Raltegravir potassium 💬 		--[4] 13, 26, 93, 265 💬
195RhuDex 100 mg (127 mg RhuDex choline salt) granules[1] Choline[1] Choline 💬 --[1] 93 💬
196RhuDex 25 mg (31.75 mg RhuDex choline salt) granules[1] Choline[1] Choline 💬 --[1] 93 💬
197RhuDex 50 mg (63.5 mg RhuDex choline salt) granules[1] Choline[1] Choline 💬 --[1] 93 💬
198RhuDex choline salt[1] Choline[1] Choline 💬 --[1] 93 💬
199Rifampicin[1] Rifampin[2] Rifampin ,
Rifampicin sodium 💬 		--[6] 6, 13, 17, 46, 93, 299 💬
200Rifaximin[1] Rifaximin[1] Rifaximin 💬 --[8] 6, 65, 93, 96, 97, 99, 296, 299 💬
201Risedronic acid[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[3] 93, 95, 274 💬
202RITUXIMAB[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[54] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
203S-adenosyl-L-methionine[1] Methionine[1] Methionine 💬 --[1] 93 💬
204S-adenosyl-methionine (SAMe) capsules[1] Methionine[1] Methionine 💬 --[1] 93 💬
205Saroglitazar[1] Saroglitazar[2] Saroglitazar ,
Saroglitazar magnesium 💬 		[3] PPARA,
PPARD,
PPARG 💬 		[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
206SAROGLITAZAR MAGNESIUM[2] Magnesium,
Saroglitazar		[2] Saroglitazar ,
Saroglitazar magnesium 💬 		[3] PPARA,
PPARD,
PPARG 💬 		[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
207Saroglitazar Magnesium 1 mg[2] Magnesium,
Saroglitazar		[2] Saroglitazar ,
Saroglitazar magnesium 💬 		[3] PPARA,
PPARD,
PPARG 💬 		[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
208Saroglitazar Magnesium 2 mg[2] Magnesium,
Saroglitazar		[2] Saroglitazar ,
Saroglitazar magnesium 💬 		[3] PPARA,
PPARD,
PPARG 💬 		[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
209Saroglitazar magnesium 4 mg[2] Magnesium,
Saroglitazar		[2] Saroglitazar ,
Saroglitazar magnesium 💬 		[3] PPARA,
PPARD,
PPARG 💬 		[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
210SELADELPAR[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[2] 93, 94 💬
211Seladelpar 10 mg[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
212Seladelpar 10 mg Capsule[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
213Seladelpar 10 mg or less[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
214Seladelpar 5 mg[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
215Seladelpar 5 mg Capsule[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
216Seladelpar 5-10 mg[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
217SETANAXIB[1] Setanaxib---[2] 93, 218 💬
218SETANAXIBProduct Code: GKT137831Pharmaceutical Form: Film-coated tabletINN or Proposed INN: SetanaxibCAS Number: 1218942-37-0Current Sponsor code: GKT137831Other descriptive name: GYPP-06 (GKT137831 free base), C10071301-DConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 93 💬
219Sortis----[1] 93 💬
220Sortis 10 mg----[1] 93 💬
221Standard of Care: UDCA----[1] 93 💬
222Standardized meal----[2] 93, 94 💬
223Sublimated mare milk----[1] 93 💬
224T cell injection targeting CD19 chimeric antigen receptor----[7] 46, 49, 51, 53, 63, 93, 300 💬
225TAUROURSODEOXYCHOLIC ACID[1] Tauroursodeoxycholic acid[1] Taurursodiol 💬 --[5] 2, 28, 93, 299, 302 💬
226Tauroursodeoxycholic Acid Capsules[1] Tauroursodeoxycholic acid[1] Taurursodiol 💬 --[1] 93 💬
227TDF/FTC/LPV/r----[1] 93 💬
228Tenofovir[1] Tenofovir[1] Tenofovir 💬 --[8] 2, 6, 13, 25, 26, 93, 265, 325 💬
229Tenofovir disoproxil[2] Tenofovir,
Tenofovir disoproxil		[4] Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--[3] 6, 93, 265 💬
230Tetrathiomolybdate[1] Tetrathiomolybdate---[3] 85, 93, 171 💬
231Thiamine[1] Thiamine[3] Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--[5] 8, 13, 93, 265, 340 💬
232Tiamin DAK----[2] 93, 97 💬
233Tiamin SAD----[2] 93, 97 💬
234Tigecycline[1] Tigecycline[1] Tigecycline 💬 --[2] 93, 299 💬
235TQA3526----[1] 93 💬
236Tropifexor[1] Tropifexor[1] Tropifexor 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
237UDCA----[2] 93, 94 💬
238UDCA (Ursodeoxycholic acid)[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
239Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation----[2] 93, 296 💬
240Ursodeoxycholic acid[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[10] 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
241Ursodeoxycholic Acid (URSO)[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
242Ursodeoxycholic Acid 300mg capsule[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
243Ursodeoxycholic Acid 300mg tablet[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
244Ursodeoxycholic Acid Capsules[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
245Ursodeoxycholic acid combination of immunosuppressive agents[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[2] 93, 95 💬
246Ursodeoxycholic acid combined with total glucosides of paeony[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
247Ursodeoxycholic acid only[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
248Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)[2] Methylprednisolone,
Ursodeoxycholic acid		[3] Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93 💬
249Ursodeoxycholsäure----[1] 93 💬
250Ursodiol----[5] 8, 20, 93, 234, 299 💬
251Ursofalk----[4] 93, 94, 96, 97 💬
252Ursofalk® 500 mg film-coated tablets----[1] 93 💬
253Ursofalk® 500 mg Filmtabletten----[1] 93 💬
254Ursofalk® capsules----[1] 93 💬
255Ustekinumab[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
256Ustekinumab 180 mg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
257Ustekinumab 45 mg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 93, 96 💬
258Ustekinumab 90 mg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[6] 49, 50, 56, 93, 96, 97 💬
259Vitamin D[1] Vitamin D---[26] 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
260Volixibat[1] Volixibat[2] Volixibat potassium ,
Volixibat 💬 		--[2] 93, 94 💬
261Volixibat potassium[2] Potassium,
Volixibat		[3] Potassium ,
Volixibat potassium ,
Volixibat 💬 		--[2] 93, 94 💬
262VolixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: volixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral use[1] Volixibat[2] Volixibat potassium ,
Volixibat 💬 		--[1] 93 💬
263Zoledronic acid[1] Zoledronic acid[5] Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[16] 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬